If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...
French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and ...
Innovative semaglutide hydrogel may revolutionize diabetes treatment by reducing the need for injections to just once a month ...
GLP-1 drugs such as Ozempic and Wegovy are booming among consumers. That means Americans are downsizing in fitting rooms and ...
In this article, we take a look at six biotech companies focused on bringing drugs to treat obesity to the market.
Semaglutide, a GLP-1 analog, may influence lipid metabolism and adipose tissue regulation by interacting with adipocytes, ...
Ty J. Gluckman, MD, FACC, FAHA, of Providence St. Joseph Health, emphasizes the need for better prevention of cardiovascular risks and discusses upcoming advances in glucagon-like peptide 1 (GLP-1) ...
GLP-1 agonists may improve the disease course for a host of neurological and psychiatric disorders tied to inflammation, ...
In people with diabetes, the "oatzempic" online diet fad may lead to increased glucose, decreased muscle mass, and ...
Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results